155 related articles for article (PubMed ID: 23160697)
21. [Liposomal cytarabine for the treatment of leptomeningeal dissemination of central nervous system tumours in children and adolescents].
Moreno L; García Ariza MA; Cruz O; Calvo C; Fuster JL; Salinas JA; Moscardo C; Portugal R; Merino JM; Madero L
An Pediatr (Barc); 2016 Nov; 85(5):274.e1-274.e8. PubMed ID: 27086069
[TBL] [Abstract][Full Text] [Related]
22. Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series.
Chamberlain MC
J Neurooncol; 2012 Aug; 109(1):143-8. PubMed ID: 22539243
[TBL] [Abstract][Full Text] [Related]
23. Complications related to the use of an intraventricular access device for the treatment of leptomeningeal metastases from solid tumor: a single centre experience in 112 patients.
Zairi F; Le Rhun E; Bertrand N; Boulanger T; Taillibert S; Aboukais R; Assaker R; Chamberlain MC
J Neurooncol; 2015 Sep; 124(2):317-23. PubMed ID: 26070555
[TBL] [Abstract][Full Text] [Related]
24. Response of primary leptomeningeal melanoma to intrathecal recombinant interleukin-2. A case report.
Fathallah-Shaykh HM; Zimmerman C; Morgan H; Rushing E; Schold SC; Unwin DH
Cancer; 1996 Apr; 77(8):1544-50. PubMed ID: 8608541
[TBL] [Abstract][Full Text] [Related]
25. Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era.
Park JH; Kim YJ; Lee JO; Lee KW; Kim JH; Bang SM; Chung JH; Kim JS; Lee JS
Lung Cancer; 2012 Jun; 76(3):387-92. PubMed ID: 22186628
[TBL] [Abstract][Full Text] [Related]
26. Liposomal cytarabine given concomitantly with radiotherapy in a patient with leptomeningeal metastasis from breast cancer.
Glas M; Stuplich M; Tschampa H; Urbach H; Rasch K; Herrlinger U
J Neurol; 2008 Nov; 255(11):1838-9. PubMed ID: 18661166
[No Abstract] [Full Text] [Related]
27. Liposomal cytarabine in neoplastic meningitis from primary brain tumors: a single institutional experience.
Gaviani P; Corsini E; Salmaggi A; Lamperti E; Botturi A; Erbetta A; Milanesi I; Legnani F; Pollo B; Silvani A
Neurol Sci; 2013 Dec; 34(12):2151-7. PubMed ID: 23525755
[TBL] [Abstract][Full Text] [Related]
28. [Diagnosis and therapy of meningosis neoplastica].
Schabet M; Bamberg M; Dichgans J
Nervenarzt; 1992 Jun; 63(6):317-27. PubMed ID: 1635613
[TBL] [Abstract][Full Text] [Related]
29. Pediatric leptomeningeal metastases: outcome following combined therapy.
Chamberlain MC
J Child Neurol; 1997 Jan; 12(1):53-9. PubMed ID: 9010796
[TBL] [Abstract][Full Text] [Related]
30. Leptomeningeal Metastasis in a Breast Cancer Treated with Two Lines of Intrathecal Chemotherapy - a Case Report.
Mikudova V; Rejlekova K; Gyarfas J; Oravcova I; Chovanec M; Mardiak J; Mego M
Klin Onkol; 2019; 32(2):139-142. PubMed ID: 30995855
[TBL] [Abstract][Full Text] [Related]
31. Clinical experience using intrathecal liposomal cytarabine to manage neoplastic meningitis in three patients with acute promyelocytic leukemia.
Duarte RF; Arnan M; Sánchez-Ortega I; de Llano MP; Abellán PF
Leuk Res; 2011 Jul; 35(7):e128-30. PubMed ID: 21501870
[No Abstract] [Full Text] [Related]
32. Leptomeningeal metastasis.
Chamberlain MC
Semin Neurol; 2010 Jul; 30(3):236-44. PubMed ID: 20577930
[TBL] [Abstract][Full Text] [Related]
33. Leptomeningeal metastasis.
Chamberlain MC
Curr Opin Neurol; 2009 Dec; 22(6):665-74. PubMed ID: 19738466
[TBL] [Abstract][Full Text] [Related]
34. The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement.
Castagnola C; Nozza A; Corso A; Bernasconi C
Haematologica; 1997; 82(5):577-80. PubMed ID: 9407724
[TBL] [Abstract][Full Text] [Related]
35. Neurological and cytological response as potential early predictors of time-to-progression and overall survival in patients with leptomeningeal carcinomatosis treated with intrathecal liposomal cytarabine: a retrospective cohort study.
Fusco JP; Castañón E; Carranza OE; Zubiri L; Martín P; Espinós J; Rodríguez J; Santisteban M; Aramendía JM; Gil-Bazo I
J Neurooncol; 2013 Dec; 115(3):429-35. PubMed ID: 24037499
[TBL] [Abstract][Full Text] [Related]
36. Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen.
Fizazi K; Asselain B; Vincent-Salomon A; Jouve M; Dieras V; Palangie T; Beuzeboc P; Dorval T; Pouillart P
Cancer; 1996 Apr; 77(7):1315-23. PubMed ID: 8608509
[TBL] [Abstract][Full Text] [Related]
37. Response to intrathecal infusions of Depocyt® in secondary diffuse leptomeningeal gliomatosis. A case report.
Beauchesne P; Blonski M; Brissart H
In Vivo; 2011; 25(6):991-3. PubMed ID: 22021694
[TBL] [Abstract][Full Text] [Related]
38. Management of adult patients receiving intraventricular chemotherapy for the treatment of leptomeningeal metastasis.
Aiello-Laws L; Rutledge DN
Clin J Oncol Nurs; 2008 Jun; 12(3):429-35. PubMed ID: 18515241
[TBL] [Abstract][Full Text] [Related]
39. Targeted treatment and immunotherapy in leptomeningeal metastases from melanoma.
Geukes Foppen MH; Brandsma D; Blank CU; van Thienen JV; Haanen JB; Boogerd W
Ann Oncol; 2016 Jun; 27(6):1138-1142. PubMed ID: 26961150
[TBL] [Abstract][Full Text] [Related]
40. Safety and toxicity of intrathecal liposomal cytarabine (Depocyte) in children and adolescents with recurrent or refractory brain tumors: a multi-institutional retrospective study.
Benesch M; Siegler N; Hoff Kv; Lassay L; Kropshofer G; Müller H; Sommer C; Rutkowski S; Fleischhack G; Urban C
Anticancer Drugs; 2009 Oct; 20(9):794-9. PubMed ID: 19617818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]